Top Markets
#1 Seeker Seeker +146.01%
#2 MowCat MowCat +109.02%
#3 AI XOVIA AI XOVIA +103.40%
#4 Helium Helium +97.25%
#5 Pons Pons +43.39%
#6 UnifAI Network UnifAI Network +33.44%
#7 Zora Zora +30.95%
#8 Bounce Bounce +22.78%
#9 Zylo Ecosystem Zylo Ecosystem +22.03%
#10 pipedog pipedog +15.70%
Coin of the day
Seeker Seeker
Innstillinger
Språk
NORSK
Valuta
USD
Tema
CinCor Pharma, Inc. CinCor Pharma, Inc.

CinCor Pharma, Inc.

CINC
Rangering i aksjer #11594
CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical... CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical development phase, dedicated to pioneering therapeutic solutions for cardiovascular and renal conditions. At the core of its pipeline is CIN-107, an investigational compound currently undergoing Phase II clinical trials for indications such as hypertension, primary aldosteronism, and various other cardio-renal disorders. Additionally, CIN-107 is in Phase I clinical evaluation for its potential in treating chronic kidney diseases. The company holds a significant licensing agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. Established in 2018, CinCor Pharma, Inc. maintains its principal operations in Boston, Massachusetts.
Aksjekurs
$29.06
Sist synkronisert: 2023-02-23
Markedsverdi
$682.73M
Endring (1 dag)
-0.48%
Endring (1 år)
0.00%
Land
US
Handel CinCor Pharma, Inc. (CINC)

Kategori

Healthcare
Aksjeprishistorikk for CinCor Pharma, Inc. (CINC)
Høyeste sluttskurs: $29.26 den 2023-02-01

Laveste sluttskurs: $16.50 den 2022-01-01
Aksjeprishistorikk for CinCor Pharma, Inc. fra 2022 til 2026
Årlig aksjeprisytelse
År Ytelse
2023 146.11%
2022 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH